TNFSF10 and neoplasm: We performed experiments in which tumor-bearing mice were injected intratumorally (i.t.)with TRAIL (1 μg in 50 μL) and/or intraperitoneally (i.p.)with ABT-737 (75 mg/kg) on days 0 and 3 after grouping (Figure 7B and 7C).